Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-24 | 166.62 | 150.48 | 10.66p | 18.3 | 0.2 | +103% | 10.08p | 0.0% |
31-Mar-25 | 376.53 | 328.67 | 13.02p | 15.0 | 0.7 | +22% | 12.06p | 0.0% |
31-Mar-26 | 387.58 | 337.31 | 13.46p | 14.5 | 4.3 | +3% | 12.45p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Current | 1 week ago | 1 month ago | 3 months ago | 6 months ago | 1 year ago | |
---|---|---|---|---|---|---|
Revenue (£m) | ||||||
31-Mar-2025 | 376 | 376 | 375 | 166 | 170 | 163 |
31-Mar-2026 | 388 | 388 | 387 | 171 | 174 | n/a |
Earnings | ||||||
31-Mar-2025 | 13.02p | 13.02p | 12.92p | 10.88p | 11.00p | 10.96p |
31-Mar-2026 | 13.46p | 13.46p | 13.37p | 11.15p | 11.30p | n/a |
Dividend | ||||||
31-Mar-2025 | 12.06p | 12.06p | 12.02p | 10.12p | 10.14p | 10.03p |
31-Mar-2026 | 12.45p | 12.45p | 12.39p | 10.35p | 10.57p | n/a |
Recommendations | ||||||
Strong Buy | 4 | 4 | 4 | 1 | 2 | 2 |
Buy | 5 | 5 | 4 | 1 | 4 | 3 |
Neutral | 4 | 4 | 4 | 6 | 6 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
No. of Brokers | 13 | 13 | 12 | 8 | 12 | 14 |
Average Rec | 7.50 | 7.50 | 7.50 | 5.94 | 6.67 | 5.89 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 194.70p |
Change Today | 1.00p |
% Change | 0.52 % |
52 Week High | 203.20 |
52 Week Low | 156.40 |
Volume | 7,029,686 |
Shares Issued | 2,040.57m |
Market Cap | £3,972.98m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 5 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 13 |
Latest | Previous | |
---|---|---|
3rd Interim | 2nd Interim | |
Ex-Div | 29-Feb-24 | 30-Nov-23 |
Paid | 08-Apr-24 | 11-Jan-24 |
Amount | 2.40p | 2.40p |
Time | Volume / Share Price |
15:48 | 2,051,079 @ 193.40p |
15:48 | 2,051,079 @ 193.40p |
16:35 | 1,567,765 @ 194.70p |
16:35 | 1 @ 194.70p |
16:35 | 638 @ 194.70p |
Finance Director | Martin McGann |
CEO | Andrew Jones |
Chair | Alistair Elliott |
You are here: research